<DOC>
	<DOCNO>NCT02863809</DOCNO>
	<brief_summary>This phase I/II prospective , randomize , multi-center , double-masked , vehicle-controlled clinical trial evaluate safety efficacy corneal collagen cross-linking keratoprosthesis carrier tissue subject candidate high-risk keratoprosthesis implantation history corneal melt autoimmune disease candidate traditional corneal transplant .</brief_summary>
	<brief_title>Vision Restoration With Collagen Crosslinked Boston Keratoprosthesis Unit</brief_title>
	<detailed_description>The study multi-center , parallel , randomize , double-blinded study subsequent follow-up period two year . Eight-four subject across twelve site randomize 1:1 receive either corneal tissue cross-linked cross-linked ( No UVA light source ) . Cross-linking term refers link polymer ( long chain ) molecules chemical bond . It believe cross-linking cornea make cornea strong resistant degradation . Tissue Bank International ( Orlando site ) supply donor tissue Avedro Inc ( Waltham MA ) supply riboflavin UV light source . Staff Tissue Bank International administer riboflavin dextran solution perform cross-linking procedure accord one randomization group ship mask donor cornea study sit Boston Keratoprosthesis ( B-KPro ) implantation .</detailed_description>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Riboflavin</mesh_term>
	<mesh_term>Dextrans</mesh_term>
	<criteria>Willing able provide write informed consent Willing able comply study assessment full duration study Age â‰¥ 18 year Candidate Boston Keratoprosthesis / Cornea transplant In generally good stable overall health Patients eye risk cornea sterile ulcer include : Autoimmune disease ( mucus membrane pemphigoid , StevensJohnson syndrome , systemic lupus erythematosis , rheumatoid arthritis , autoimmune disease ) ; OR History previous sterile cornea ulceration require cornea transplant Age &lt; 18 year Inability provide write informed consent comply study assessment full duration study No minimal tear production evidence keratinization bulbar conjunctiva Corneal ocular surface infection within 30 day prior study entry Ocular periocular malignancy Inability wear contact lens due lid abnormality shorten fornix Signs current infection , include fever current treatment antibiotic Pregnancy ( positive pregnancy test ) lactate Participation another simultaneous interventional medical investigation trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Keratolysis</keyword>
	<keyword>Corneal Melting</keyword>
	<keyword>Boston KPro</keyword>
	<keyword>Keratoprosthesis</keyword>
</DOC>